Revolutionary Cardiovascular Screening with Retinal Imaging
Did you know that half of heart attacks occur in people without prior symptoms? Oculomex uses advanced AI technology to analyze retinal images, enabling early and precise detection of potential cardiovascular issues. Our solution is transforming how cardiovascular health is monitored, making early interventions possible and saving lives.
Why Early Detection Matters
Cardiovascular conditions often go unnoticed until it’s too late. With Oculomex, early detection becomes accessible, non-invasive, and more affordable, making a difference in primary care settings and ensuring timely intervention.
Simple, Efficient, Accurate
How It Works
Capture Key Health Data
Retinal images and essential patient information are collected and uploaded quickly via our secure platform.
AI-Driven Analysis
Our cutting-edge algorithms analyze the data and generate an immediate cardiovascular risk assessment.
Specialist Referral
Depending on the results, patients are referred to a specialist for personalized care and early treatment.
Our Technology
The retina offers a window into cardiovascular health, reflecting the body’s overall state through its blood vessels. By analyzing changes in the retina, such as narrowing or twisting of blood vessels, Oculomex can detect signs of conditions like hypertension or atherosclerosis early on.
Using AI, we enhance this capability by improving the accuracy and speed of diagnosis, delivering results within seconds and making life-saving interventions possible before symptoms even appear.
• Fast & Easy Risk Detection: Accessible from primary care settings with a non-invasive procedure.
• Advanced Diagnostics: Harnessing AI for more accurate, reliable assessments.
• Preventive Care: Early detection ensures personalized treatment, minimizing the chances of severe cardiovascular events.
• Efficient Risk Identification: Identify at-risk patients early, ensuring timely and appropriate medical intervention.
• Cost-Effective: Early diagnosis reduces the need for more complex and expensive treatments down the line.
• Improved Patient Care Flow: Streamlined referral to specialists, ensuring patients receive specialized care when necessary.
Who we are
Management team
Francisco Palao, PhD, MBA
Francisco Palao Reinés is an entrepreneur and AI specialist with more than 25 years’ experience building technology ventures and helping teams take ambitious ideas into real-world use.
He has founded and scaled multiple AI-focused startups (including businesses that were later acquired), and is known for his work on “purpose-led” innovation—creating frameworks and communities that support founders and organisations to build products with measurable impact.
He holds a PhD in Artificial Intelligence and an MBA.
Prof Alejandro Frangi FREng
Alejandro Frangi is a recognised leader in computational medicine and medical imaging AI, focused on translating advanced modelling and machine learning into tools that can be used safely and confidently in real clinical settings.
Alongside his role at Oculomex, he holds senior academic appointments in the UK, including the Bicentenary Turing Chair in Computational Medicine and the Royal Academy of Engineering Chair in Emerging Technologies. His work spans AI-enabled imaging, precision computational medicine, and in silico trials (virtual trials), helping to strengthen the evidence needed to support adoption of new healthcare technologies.
At Oculomex, Alejandro provides scientific leadership across research direction, clinical validation planning, and translation strategy, ensuring the company’s approach remains evidence-led, clinically relevant, and aligned with how healthcare systems evaluate and adopt innovation.
Meet the Oculomex Partners
Our collaboration with industry leaders like Boston Scientific, Purpose Alliance, and the University of Manchester fuels innovation in cardiovascular risk detection. Together, we turn cutting-edge research into real-world solutions, ensuring our technology reaches those who need it most, creating a lasting impact on global health.
